1 Market Overview
    1.1 Product Overview and Scope of Natural Killer Cell Therapy
    1.2 Global Natural Killer Cell Therapy Market Size and Forecast
    1.3 China Natural Killer Cell Therapy Market Size and Forecast
    1.4 China Percentage in Global Market
        1.4.1 By Revenue, China Natural Killer Cell Therapy Share in Global Market, 2020-2031
        1.4.2 Natural Killer Cell Therapy Market Size: China VS Global, 2020-2031
    1.5 Natural Killer Cell Therapy Market Dynamics
        1.5.1 Natural Killer Cell Therapy Market Drivers
        1.5.2 Natural Killer Cell Therapy Market Restraints
        1.5.3 Natural Killer Cell Therapy Industry Trends
        1.5.4 Natural Killer Cell Therapy Industry Policy
2 Competitive Landscape by Company
    2.1 Global Natural Killer Cell Therapy Revenue by Company, 2020-2025
    2.2 Global Natural Killer Cell Therapy Participants, Market Position (Tier 1, Tier 2, and Tier 3)
    2.3 Global Natural Killer Cell Therapy Concentration Ratio
    2.4 Global Natural Killer Cell Therapy Mergers & Acquisitions, Expansion Plans
    2.5 Global Natural Killer Cell Therapy Manufacturers Product Type
    2.6 Global Geographic Distribution of Natural Killer Cell Therapy Companies
3 China Competitive Situation by Company
    3.1 China Natural Killer Cell Therapy Revenue by Company, 2020-2025
    3.2 China Natural Killer Cell Therapy Natural Killer Cell Therapy Participants, Market Position (Tier 1, Tier 2, and Tier 3)
    3.3 China Natural Killer Cell Therapy Market, Revenue Percentage of Local Players VS Foreign Players (2020-2031)
4 Industry Chain Analysis
    4.1 Natural Killer Cell Therapy Industry Chain
    4.2 Natural Killer Cell Therapy Upstream Analysis
    4.3 Natural Killer Cell Therapy Midstream Analysis
    4.4 Natural Killer Cell Therapy Downstream Analysis
5 Sights by Type
    5.1 Natural Killer Cell Therapy Classification by Type
        5.1.1 NK Cell Therapy
        5.1.2 CAR-NK Cell Therapy
    5.2 by Type, Global Natural Killer Cell Therapy Market Size & CAGR, 2020 VS 2024 VS 2031
    5.3 by Type, Global Natural Killer Cell Therapy Market Size, 2020-2031
6 Sights by Application
    6.1 Natural Killer Cell Therapy Segment by Application
        6.1.1 Cancer
        6.1.2 Infectious Diseases
        6.1.3 Gastrointestinal Diseases
        6.1.4 Beauty and Anti-Aging
        6.1.5 Others
    6.2 by Application, Global Natural Killer Cell Therapy Market Size & CAGR, 2020 VS 2024 VS 2031
    6.3 by Application, Global Natural Killer Cell Therapy Market Size, 2020-2031
7 Sights by Region
    7.1 By Region, Global Natural Killer Cell Therapy Market Size, 2020 VS 2024 VS 2031
    7.2 By Region, Global Natural Killer Cell Therapy Market Size, 2020-2031
    7.3 North America
        7.3.1 North America Natural Killer Cell Therapy Market Size & Forecasts, 2020-2031
        7.3.2 By Country, North America Natural Killer Cell Therapy Market Size Market Share
    7.4 Europe
        7.4.1 Europe Natural Killer Cell Therapy Market Size & Forecasts, 2020-2031
        7.4.2 By Country, Europe Natural Killer Cell Therapy Market Size Market Share
    7.5 Asia Pacific
        7.5.1 Asia Pacific Natural Killer Cell Therapy Market Size & Forecasts, 2020-2031
        7.5.2 By Country/Region, Asia Pacific Natural Killer Cell Therapy Market Size Market Share
    7.6 South America
        7.6.1 South America Natural Killer Cell Therapy Market Size & Forecasts, 2020-2031
        7.6.2 By Country, South America Natural Killer Cell Therapy Market Size Market Share
    7.7 Middle East & Africa
8 Sights by Country Level
    8.1 By Country, Global Natural Killer Cell Therapy Market Size & CAGR，2020 VS 2024 VS 2031
    8.2 By Country, Global Natural Killer Cell Therapy Market Size, 2020-2031
    8.3 United States
        8.3.1 United States Natural Killer Cell Therapy Market Size, 2020-2031
        8.3.2 By Company, United States Natural Killer Cell Therapy Revenue Market Share, 2024
        8.3.3 by Type, United States Natural Killer Cell Therapy Revenue Market Share, 2024 VS 2031
        8.3.4 by Application, United States Natural Killer Cell Therapy Revenue Market Share, 2024 VS 2031
    8.4 Europe
        8.4.1 Europe Natural Killer Cell Therapy Market Size, 2020-2031
        8.4.2 By Company, Europe Natural Killer Cell Therapy Revenue Market Share, 2024
        8.4.3 by Type, Europe Natural Killer Cell Therapy Revenue Market Share, 2024 VS 2031
        8.4.4 by Application, Europe Natural Killer Cell Therapy Revenue Market Share, 2024 VS 2031
    8.5 China
        8.5.1 China Natural Killer Cell Therapy Market Size, 2020-2031
        8.5.2 By Company, China Natural Killer Cell Therapy Revenue Market Share, 2024
        8.5.3 by Type, China Natural Killer Cell Therapy Revenue Market Share, 2024 VS 2031
        8.5.4 by Application, China Natural Killer Cell Therapy Revenue Market Share, 2024 VS 2031
    8.6 Japan
        8.6.1 Japan Natural Killer Cell Therapy Market Size, 2020-2031
        8.6.2 By Company, Japan Natural Killer Cell Therapy Revenue Market Share, 2024
        8.6.3 by Type, Japan Natural Killer Cell Therapy Revenue Market Share, 2024 VS 2031
        8.6.4 by Application, Japan Natural Killer Cell Therapy Revenue Market Share, 2024 VS 2031
    8.7 South Korea
        8.7.1 South Korea Natural Killer Cell Therapy Market Size, 2020-2031
        8.7.2 By Company, South Korea Natural Killer Cell Therapy Revenue Market Share, 2024
        8.7.3 by Type, South Korea Natural Killer Cell Therapy Revenue Market Share, 2024 VS 2031
        8.7.4 by Application, South Korea Natural Killer Cell Therapy Revenue Market Share, 2024 VS 2031
    8.8 Southeast Asia
        8.8.1 Southeast Asia Natural Killer Cell Therapy Market Size, 2020-2031
        8.8.2 By Company, Southeast Asia Natural Killer Cell Therapy Revenue Market Share, 2024
        8.8.3 by Type, Southeast Asia Natural Killer Cell Therapy Revenue Market Share, 2024 VS 2031
        8.8.4 by Application, Southeast Asia Natural Killer Cell Therapy Revenue Market Share, 2024 VS 2031
    8.9 India
        8.9.1 India Natural Killer Cell Therapy Market Size, 2020-2031
        8.9.2 By Company, India Natural Killer Cell Therapy Revenue Market Share, 2024
        8.9.3 by Type, India Natural Killer Cell Therapy Revenue Market Share, 2024 VS 2031
        8.9.4 by Application, India Natural Killer Cell Therapy Revenue Market Share, 2024 VS 2031
    8.10 Middle East & Africa
        8.10.1 Middle East & Africa Natural Killer Cell Therapy Market Size, 2020-2031
        8.10.2 By Company, Middle East & Africa Natural Killer Cell Therapy Revenue Market Share, 2024
        8.10.3 by Type, Middle East & Africa Natural Killer Cell Therapy Revenue Market Share, 2024 VS 2031
        8.10.4 by Application, Middle East & Africa Natural Killer Cell Therapy Revenue Market Share, 2024 VS 2031
9 Company Profile
    9.1 Nektar Therapeutics
        9.1.1 Nektar Therapeutics Company Information, Head Office, Market Area, and Industry Position
        9.1.2 Nektar Therapeutics Company Profile and Main Business
        9.1.3 Nektar Therapeutics Natural Killer Cell Therapy Models, Specifications, and Application
        9.1.4 Nektar Therapeutics Natural Killer Cell Therapy Revenue and Gross Margin, 2020-2025
        9.1.5 Nektar Therapeutics Recent Developments
    9.2 ImmunityBio, Inc
        9.2.1 ImmunityBio, Inc Company Information, Head Office, Market Area, and Industry Position
        9.2.2 ImmunityBio, Inc Company Profile and Main Business
        9.2.3 ImmunityBio, Inc Natural Killer Cell Therapy Models, Specifications, and Application
        9.2.4 ImmunityBio, Inc Natural Killer Cell Therapy Revenue and Gross Margin, 2020-2025
        9.2.5 ImmunityBio, Inc Recent Developments
    9.3 GC Cell
        9.3.1 GC Cell Company Information, Head Office, Market Area, and Industry Position
        9.3.2 GC Cell Company Profile and Main Business
        9.3.3 GC Cell Natural Killer Cell Therapy Models, Specifications, and Application
        9.3.4 GC Cell Natural Killer Cell Therapy Revenue and Gross Margin, 2020-2025
        9.3.5 GC Cell Recent Developments
    9.4 Affimed
        9.4.1 Affimed Company Information, Head Office, Market Area, and Industry Position
        9.4.2 Affimed Company Profile and Main Business
        9.4.3 Affimed Natural Killer Cell Therapy Models, Specifications, and Application
        9.4.4 Affimed Natural Killer Cell Therapy Revenue and Gross Margin, 2020-2025
        9.4.5 Affimed Recent Developments
    9.5 Innate Pharma SA
        9.5.1 Innate Pharma SA Company Information, Head Office, Market Area, and Industry Position
        9.5.2 Innate Pharma SA Company Profile and Main Business
        9.5.3 Innate Pharma SA Natural Killer Cell Therapy Models, Specifications, and Application
        9.5.4 Innate Pharma SA Natural Killer Cell Therapy Revenue and Gross Margin, 2020-2025
        9.5.5 Innate Pharma SA Recent Developments
    9.6 Fate Therapeutics
        9.6.1 Fate Therapeutics Company Information, Head Office, Market Area, and Industry Position
        9.6.2 Fate Therapeutics Company Profile and Main Business
        9.6.3 Fate Therapeutics Natural Killer Cell Therapy Models, Specifications, and Application
        9.6.4 Fate Therapeutics Natural Killer Cell Therapy Revenue and Gross Margin, 2020-2025
        9.6.5 Fate Therapeutics Recent Developments
    9.7 Glycostem Therapeutics
        9.7.1 Glycostem Therapeutics Company Information, Head Office, Market Area, and Industry Position
        9.7.2 Glycostem Therapeutics Company Profile and Main Business
        9.7.3 Glycostem Therapeutics Natural Killer Cell Therapy Models, Specifications, and Application
        9.7.4 Glycostem Therapeutics Natural Killer Cell Therapy Revenue and Gross Margin, 2020-2025
        9.7.5 Glycostem Therapeutics Recent Developments
    9.8 Dragonfly Therapeutics
        9.8.1 Dragonfly Therapeutics Company Information, Head Office, Market Area, and Industry Position
        9.8.2 Dragonfly Therapeutics Company Profile and Main Business
        9.8.3 Dragonfly Therapeutics Natural Killer Cell Therapy Models, Specifications, and Application
        9.8.4 Dragonfly Therapeutics Natural Killer Cell Therapy Revenue and Gross Margin, 2020-2025
        9.8.5 Dragonfly Therapeutics Recent Developments
    9.9 Nkarta Therapeutics
        9.9.1 Nkarta Therapeutics Company Information, Head Office, Market Area, and Industry Position
        9.9.2 Nkarta Therapeutics Company Profile and Main Business
        9.9.3 Nkarta Therapeutics Natural Killer Cell Therapy Models, Specifications, and Application
        9.9.4 Nkarta Therapeutics Natural Killer Cell Therapy Revenue and Gross Margin, 2020-2025
        9.9.5 Nkarta Therapeutics Recent Developments
    9.10 Fortress Biotech
        9.10.1 Fortress Biotech Company Information, Head Office, Market Area, and Industry Position
        9.10.2 Fortress Biotech Company Profile and Main Business
        9.10.3 Fortress Biotech Natural Killer Cell Therapy Models, Specifications, and Application
        9.10.4 Fortress Biotech Natural Killer Cell Therapy Revenue and Gross Margin, 2020-2025
        9.10.5 Fortress Biotech Recent Developments
    9.11 Nkure
        9.11.1 Nkure Company Information, Head Office, Market Area, and Industry Position
        9.11.2 Nkure Company Profile and Main Business
        9.11.3 Nkure Natural Killer Cell Therapy Models, Specifications, and Application
        9.11.4 Nkure Natural Killer Cell Therapy Revenue and Gross Margin, 2020-2025
        9.11.5 Nkure Recent Developments
10 Conclusion
11 Appendix
    11.1 Research Methodology
    11.2 Data Source
        11.2.1 Secondary Sources
        11.2.2 Primary Sources
    11.3 Market Estimation Model
    11.4 Disclaimer